Market Value332,470,540
Total Holdings28
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RCKT / Rocket Pharmaceuticals, Inc.
RVMD / Revolution Medicines, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
MRUS / Merus N.V.
AMLX / Amylyx Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
SLDB / Solid Biosciences Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
NRIX / Nurix Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
PRLD / Prelude Therapeutics Incorporated
TYRA / Tyra Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
BCAB / BioAtla, Inc.
DNLI / Denali Therapeutics Inc.
BOLD / Boundless Bio, Inc.
RNA / Avidity Biosciences, Inc.
NUVL / Nuvalent, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CMRX / Chimerix, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
TIL / Instil Bio, Inc.
ELVN / Enliven Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
MRSN / Mersana Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
ARVN / Arvinas, Inc.
SYRE / Spyre Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
APGE / Apogee Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
JSPR / Jasper Therapeutics, Inc.
ZURA / Zura Bio Limited
PSTX / Poseida Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
IMVT / Immunovant, Inc.
TERN / Terns Pharmaceuticals, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
GERN / Geron Corporation
OBIO / Orchestra BioMed Holdings, Inc.
THRD / Third Harmonic Bio, Inc.
KALV / KalVista Pharmaceuticals, Inc.
RCUS / Arcus Biosciences, Inc.
BCAX / Bicara Therapeutics Inc.
BDTX / Black Diamond Therapeutics, Inc.
REPL / Replimune Group, Inc.
ITOS / iTeos Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
QURE / uniQure N.V.
KYMR / Kymera Therapeutics, Inc.
PRTA / Prothena Corporation plc
CLYM / Climb Bio, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
SMMT / Summit Therapeutics Inc.